← Leaderboards
Sujatha Kannan
Wayne State University
$8,377,903
Attributed
$14,866,910
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,866,910 · 8
By mechanism
R01$11,135,587 · 5
U01$2,757,405 · 1
K08$510,084 · 1
R21$463,834 · 1
Top collaborators
- Kannan Rangaramanujam15 shared
- Barbara Stauch Slusher9 shared
- Mary E Blue4 shared
- Nitish Vyomesh Thakor4 shared
Most similar at Wayne State University
Same institution · by research overlap
- Kang Chen$2,767,863
- Michael Curtis Petriello$3,876,796
Others in their field
Top investigators on “Microglia”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Li-Huei Tsai · Massachusetts Institute Of Technology$36,819,768
- Philip L De Jager · Columbia University Health Sciences$32,795,139
- Shilpa J Buch · University Of Kansas Medical Center$25,300,887
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
MicrogliaBrainInflammationInjuryResponseDendrimersNeuroinflammationBaseMediatingBrain InjuriesInnovationDoseAstrocytesNeurodevelopmental DisorderTargeted TreatmentCerebral PalsyPublic HealthCellsAffectAttenuatedOryctolagus CuniculusPathogenesisDisabilityProduction
Grant awards (35)
Novel Glucose dendrimers for targeting injured neurons$522,756
R01 · FY2025 · NS
Targeting glutamate carboxypeptidase in perinatal brain injury$518,490
R01 · FY2025 · NS · contact PI
Targeting glutamate carboxypeptidase in perinatal brain injury$552,328
R01 · FY2024 · NS · contact PI
Novel Glucose dendrimers for targeting injured neurons$519,500
R01 · FY2024 · NS
Targeting glutamate carboxypeptidase in perinatal brain injury$571,782
R01 · FY2023 · NS · contact PI
Targeted Therapies for Rett Syndrome$378,653
R01 · FY2023 · NS · contact PI
Targeting glutamate carboxypeptidase in perinatal brain injury$537,837
R01 · FY2022 · NS · contact PI
Targeted Therapies for Rett Syndrome$397,162
R01 · FY2022 · NS · contact PI
Translational Technologies for Ameliorating Brain Injury$523,084
R01 · FY2021 · HL
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury$462,245
U01 · FY2021 · NS
Targeted Therapies for Rett Syndrome$400,082
R01 · FY2021 · NS · contact PI
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury$750,175
U01 · FY2020 · NS
Translational Technologies for Ameliorating Brain Injury$523,084
R01 · FY2020 · HL
Targeting glutamate carboxypeptidase in perinatal brain injury$408,400
R01 · FY2020 · NS · contact PI
Targeted Therapies for Rett Syndrome$405,934
R01 · FY2020 · NS · contact PI
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury$761,031
U01 · FY2019 · NS
Translational Technologies for Ameliorating Brain Injury$514,896
R01 · FY2019 · HL
Targeted Therapies for Rett Syndrome$434,798
R01 · FY2019 · NS · contact PI
Targeting glutamate carboxypeptidase in perinatal brain injury$408,400
R01 · FY2019 · NS · contact PI
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury$783,954
U01 · FY2018 · NS
Translational Technologies for Ameliorating Brain Injury$534,896
R01 · FY2018 · HL
Targeting glutamate carboxypeptidase in perinatal brain injury$458,089
R01 · FY2018 · NS · contact PI
Targeting glutamate carboxypeptidase in perinatal brain injury$434,678
R01 · FY2017 · NS · contact PI
Dendrimer therapies for treatment of Rett Syndrome$203,883
R21 · FY2017 · NS · contact PI
Targeting glutamate carboxypeptidase in perinatal brain injury$443,366
R01 · FY2016 · NS · contact PI
Mechanisms and novel therapy in intrauterine inflammation induced brain injury$330,588
R01 · FY2016 · HD · contact PI
Dendrimer therapies for treatment of Rett Syndrome$259,951
R21 · FY2016 · NS · contact PI
Mechanisms and novel therapy in intrauterine inflammation induced brain injury$325,273
R01 · FY2015 · HD · contact PI
Mechanisms and novel therapy in intrauterine inflammation induced brain injury$324,721
R01 · FY2014 · HD · contact PI
Mechanisms and novel therapy in intrauterine inflammation induced brain injury$317,096
R01 · FY2013 · HD · contact PI
Mechanisms and novel therapy in intrauterine inflammation induced brain injury$349,694
R01 · FY2012 · HD · contact PI
Imaging and therapy of intrauterine inflammation induced perinatal brain injury$127,521
K08 · FY2010 · HD · contact PI
Imaging and therapy of intrauterine inflammation induced perinatal brain injury$127,521
K08 · FY2009 · HD · contact PI
Imaging and therapy of intrauterine inflammation induced perinatal brain injury$127,521
K08 · FY2008 · HD · contact PI
Imaging and therapy of intrauterine inflammation induced perinatal brain injury$127,521
K08 · FY2007 · HD · contact PI